Connext Achieves Milestone in CNT201 Clinical Trial for Dupuytren's Contracture Therapy Connext has successfully concluded the dose escalation portion of its CNT201 clinical trial for Dupuytren's contracture, paving the way for Phase 2 studies.

Connext Achieves Milestone in CNT201 Clinical Trial for Dupuytren's Contracture Therapy #CNT201 #Connext #Dupuytren's_Contracture